drugset / Trial / NCT02696226

Frequency of Reduced Leaflet Motion After Surgical Aortic Valve Replacement and Transcatheter Aortic Valve Replacement.

NCT02696226 ↗

Terminated 3 enrolled The Cleveland Clinic
RandomizedParallel-groupSingle-blindDiagnostic

Summary

This is a prospective, randomized pilot study in patients undergoing Sugical Aortic Valve Replacement (SAVR) and Transcatheter Aortic Valve Replacement (TAVR) to estimate the incidence of reduced leaflet motion and assess the impact of perioperative anticoagulation on the incidence of reduced leaflet motion.

Timeline

Start
2016-02
Primary completion
2017-07-28
Completion
2017-07-28

Outcome

Outcome not reported

Stopped (Enrollment): “Poor enrollment”

Drugs

EvaluationDrugModalityDoseRoute
Subject Aspirin Small molecule 81 mg —
Subject Clopidogrel Small molecule 75 mg —
Subject Warfarin Small molecule — —

Indications